RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All MHRA (UK) updates
MHRA (UK)
OTHER
Field Safety Notices: 19 to 23 October 2026
Published: 10/28/2026Detected: 10/28/2026

Summary preview

Field Safety Notices (FSNs) issued between 19 and 23 October 2026 are listed, which may require manufacturers and supply-chain partners to review product-specific safety actions and ensure appropriate communications and…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
safety
manufacturing
quality
clinical
labeling
#MHRA
#Field Safety Notice
#post-market safety
#pharmacovigilance
#recall

Official Source Document
Source Verified

Access the original document directly from MHRA.

View Official Document

More from MHRA (UK)

  • MHRA Safety Roundup: October 202610/27/2026
  • Class 2 Medicines Recall: Xeal Pharma, Clopidogrel Oral Liquids (all strengths), EL(26)A/4310/26/2026
  • Field Safety Notices: 5 to 9 October 202610/19/2026
  • Field Safety Notices: 12 to 16 October 202610/19/2026
  • Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/01310/16/2026

Get MHRA (UK) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.